SEC Form 4 · accession 0001209191-18-004652
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guy Macdonald
Officer — President and Chief Executive · Director
Period of report
Jan 19, 2018
Accepted (ET)
Jan 19, 2018 · 7:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2017 | A | 3,101 | — | A | 127,440 | D | |
| Common StockF1 | Nov 14, 2017 | A | 1,566 | — | A | 129,006 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F3 | — | Jan 19, 2018 | A | 100,000 | A | — | — | Common Stock | 100,000 | 100,000 | D |
| Employee Stock Option (Right to Buy)F4 | $6.34 | Jan 19, 2018 | A | 300,000 | A | — | Jan 18, 2028 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1These shares were purchased pursuant to the issuer's 2014 Employee Stock Purchase Plan.
- F2Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- F3These restricted stock units shall be eligible to vest upon achievement of certain performance conditions and, if such conditions are met, shall vest on January 31, 2021.
- F4Vests as to 6.25% of the shares on 4/19/2018 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/19/2022.